Response to Aflibercept Therapy in Three Types of Choroidal Neovascular Membrane in Neovascular Age-Related Macular Degeneration: Real-Life Evidence in the Czech Republic

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61988987%3A17110%2F19%3AA2102735" target="_blank" >RIV/61988987:17110/19:A2102735 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11120/19:43918460 RIV/00216208:11150/19:10395539 RIV/00179906:_____/19:10395539 RIV/00064173:_____/19:N0000146 RIV/00843989:_____/19:E0107862
Result on the web
<a href="https://downloads.hindawi.com/journals/joph/2019/2635689.pdf" target="_blank" >https://downloads.hindawi.com/journals/joph/2019/2635689.pdf</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1155/2019/2635689" target="_blank" >10.1155/2019/2635689</a>

Result language
angličtina
Original language name
Response to Aflibercept Therapy in Three Types of Choroidal Neovascular Membrane in Neovascular Age-Related Macular Degeneration: Real-Life Evidence in the Czech Republic
Original language description
Purpose. To present a cohort of treatment-naive patients with the neovascular form of age-related macular degeneration (nAMD) treated with aflibercept in a fixed regimen and evaluate the treatment response of three types of choroidal neovascular membrane (CNV)-occult (Type 1), classic (Type 2), and minimally classic (Type 4). Methods. This was a multicentre, prospective, observational consecutive case series study.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30502 - Other medical science

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2019
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)